<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl4" position="float"><object-id pub-id-type="doi">10.7554/eLife.08440.020</object-id><label>Table 4.</label><caption><p>Clinical characteristics of subjects</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.08440.020">http://dx.doi.org/10.7554/eLife.08440.020</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Control (n = 117)</th><th>PD (n = 232)</th><th>p value</th></tr></thead><tbody><tr><td>Age (years)</td><td>59.7 &#177; 11.3</td><td>61.2 &#177; 9.1</td><td>0.1</td></tr><tr><td>Years of education (years)</td><td>15.7 &#177; 2.91</td><td>15.4 &#177; 2.8</td><td>NS</td></tr><tr><td>Sex (M/F/% males)</td><td>74/43/63.2</td><td>155/77/66.8</td><td>NS</td></tr><tr><td>Handedness&#8211;R/L/A</td><td>98/11/8</td><td>210/17/5</td><td>NS</td></tr><tr><td>Striatum binding ratio</td><td>2.6 &#177; 0.6</td><td>1.4 &#177; 0.4</td><td>&lt;0.0001</td></tr><tr><td>MoCA</td><td>28.2 &#177; 1.2</td><td>27.3 &#177; 2.2</td><td>&lt;0.0001</td></tr><tr><td>Disease duration (months)</td><td>&#8211;</td><td>6.9 &#177; 7.1</td><td>&#8211;</td></tr><tr><td>MDS UPDRS part III</td><td>&#8211;</td><td>21.9 &#177; 9.1</td><td>&#8211;</td></tr><tr><td>H&amp;Y stage</td><td>&#8211;</td><td>1.6 &#177; 0.5</td><td>&#8211;</td></tr></tbody></table><table-wrap-foot><fn><p>M = male, F = female, NS = not significant, H&amp;Y: Hoehn and Yahr, PD: Parkinson's disease, MoCA, Montreal Cognitive Assessment, UPDRS, Unified Parkinson's Disease Rating Scale. Statistical differences analyzed through an unpaired t-test or chi square test. Listed values are the mean &#177; standard deviation.</p></fn></table-wrap-foot></table-wrap>